Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery

BJU International

Volumn 109, Issue 3, 2012, Pages 388-393

  Jensen, Jørgen B ^a   Ulhøi, Benedicte P ^a   Jensen, Klaus M E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

bladder cancer; lymph node; lymph node density; lymphadenectomy; radical cystectomy; TNM

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CANCER STAGING; CORRELATION ANALYSIS; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; ILIAC LYMPH NODE; INFERIOR MESENTERIC ARTERY; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; SEX DIFFERENCE; TUMOR LOCALIZATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MESENTERIC ARTERY, INFERIOR; MIDDLE AGED; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 84855920101     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10369.x     Document Type: Article

References (30)

1. Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE,. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 2001; 166: 19-23 (Pubitemid 32565332)
2. Vieweg J, Gschwend JE, Herr HW, Fair WR,. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 1999; 161: 449-54
3. Stein JP, Cai J, Groshen S, Skinner DG,. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 2003; 170: 35-41 (Pubitemid 36734405)
4. Fleischmann A, Thalmann GN, Markwalder R, Studer UE,. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 2005; 23: 2358-65 (Pubitemid 46218729)
5. Stephenson AJ, Gong MC, Campbell SC, Fergany AF, Hansel DE,. Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer. Urology 2010; 75: 382-6
6. Wiesner C, Salzer A, Thomas C, et al,. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int 2009; 104: 331-5
7. Kassouf W, Agarwal PK, Herr HW, et al,. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol 2008; 26: 121-6
8. Osawa T, Abe T, Shinohara N, et al,. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study. Int J Urol 2009; 16: 274-8
9. Sobin LH, Wittekind C,. TNM Classification of Malignant Tumors, 6th edn. New York: Wiley-Liss, 2002
10. Sobin LH, Gospodarowicz MK, Wittekind C,. TNM Classification of Malignant Tumors, 7th edn. New York: Wiley-Blackwell, 2010
11. Dangle PP, Gong MC, Bahnson RR, Pohar KS,. How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J Urol 2010; 183: 499-503
12. Roth B, Wissmeyer MP, Zehnder P, et al,. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 2010; 57: 205-11
13. Jensen JB, Ulhoi BP, Jensen KM,. Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery. BJU Int 2010; 106: 199-205
14. Jensen JB, Ulhoi BP, Jensen KM,. Size and volume of metastatic and non-metastatic lymph nodes in pelvis and lower abdomen in patients with carcinoma of the bladder undergoing radical cystectomy. Scand J Urol Nephrol 2010; 44: 291-7
15. Gschwend JE, Dahm P, Fair WR,. Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 2002; 41: 440-8 (Pubitemid 35333942)
16. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK,. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 2000; 85: 817-23 (Pubitemid 30242784)
17. Honma I, Masumori N, Sato E, et al,. Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer-analysis of role of pelvic lymph node dissection. Urology 2006; 68: 543-8 (Pubitemid 44436499)
18. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF,. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167: 1295-8 (Pubitemid 34132073)
19. Steven K, Poulsen AL,. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol 2007; 178: 1218-24 (Pubitemid 47368419)
20. Holmer M, Bendahl PO, Davidsson T, Gudjonsson S, Mansson W, Liedberg F,. Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference? World J Urol 2009; 27: 521-6
21. Konety BR, Joslyn SA, O'Donnell MA,. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 2003; 169: 946-50 (Pubitemid 36188131)
22. Wright JL, Lin DW, Porter MP,. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 2008; 112: 2401-8
23. Parkash V, Bifulco C, Feinn R, Concato J, Jain D,. To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting. Am J Clin Pathol 2010; 134: 42-9
24. Leissner J, Ghoneim MA, Abol-Enein H, et al,. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004; 171: 139-44 (Pubitemid 37549109)
25. Abol-Enein H, El-Baz M, Abd El-Hameed MA, Abdel-Latif M, Ghoneim MA,. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study-a single center experience. J Urol 2004; 172: 1818-21 (Pubitemid 39363063)
26. Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP,. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004; 171: 1830-4 (Pubitemid 38501015)
27. Jeong IG, Park J, Song K, et al,. Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed. Urol Oncol 2011; 29: 199-204
28. Jeong IG, Ro JY, Kim SC, et al,. Extranodal extension in node-positive bladder cancer: the continuing controversy. BJU Int 2010; [Epub ahead of print]. DOI: 10.1111/j.1464-410X.2010.09823.x
29. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C,. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 2006; 24: 778-89 (Pubitemid 46622045)
30. Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM, Frierson HF Jr,. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 2004; 10: 3800-6 (Pubitemid 38697615)